Metraipolis › archive › dc_bd78e252d67c

Incidence of infections in patients treated with rituximab for autoimmune disorders of hematological Interest or non-Hodgkin lymphoma — Europe PMC PMID:42105103

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42105103
DOI
10.1007/s00277-[numero omesso]-4
License (as archived)
solo-consultazione
Archived
2026-11-02T12:52:56.709Z
SHA-256 of the archived text
5ad1257f92f00eff3ca449a9b3addb5a305b05bc482b813b511412b910d8eac5
Stable URL of this page
https://metraipolis.com/documento/dc_bd78e252d67c

How to cite

Incidence of infections in patients treated with rituximab for autoimmune disorders of hematological Interest or non-Hodgkin lymphoma — Europe PMC PMID:42105103 — Europe PMC (en), https://europepmc.org/article/MED/42105103 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bd78e252d67c (Metraipolis archive dc_bd78e252d67c, sha256 5ad1257f92f00eff3ca449a9b3addb5a305b05bc482b813b511412b910d8eac5)
BibTeX
@misc{dcbd78e252d67c,
  title = {Incidence of infections in patients treated with rituximab for autoimmune disorders of hematological Interest or non-Hodgkin lymphoma — Europe PMC PMID:42105103},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42105103},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bd78e252d67c; sha256 5ad1257f92f00eff3ca449a9b3addb5a305b05bc482b813b511412b910d8eac5},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42105103. Agents can read the archived copy with the MCP tool read_document.